Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Comparison with Standard Treatments Studies comparing BPC-157 to becaplermin (the active ingredient in Regranex, an FDA-approved treatment for diabetic foot ulcers) found BPC-157 produced superior results in several parameters
Evidence Ledger: Claims vs
It improves force transmission, joint stability, and recovery
Sometimes, the injection site may feel numb or have slight bruising
The Guardian
Evidence ranges from early laboratory work to clinical trials depending on the use the sections below cover the actual data and sources
US$ 21.88
US$ 24.38
US$ 24.70
US$ 27.63
US$ 25.11
US$ 25.44
US$ 20.82
US$ 23.12
US$ 21.66
